ArticleOncotarget2017

RAS testing and cetuximab treatment for metastatic colorectal cancer: a cost-effectiveness analysis in a setting with limited health resources.

Bin Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.